Literature DB >> 2358466

Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia.

K Kobayashi1, M J Jackson, D B Tick, W E O'Brien, A L Beaudet.   

Abstract

Citrullinemia is an autosomal recessive disease caused by deficiency of argininosuccinate synthetase. In order to characterize mutations, RNA was isolated from cultured fibroblasts from 13 unrelated patients with neonatal citrullinemia. Ten mutations were identified by sequencing of amplified cDNA. Seven single base missense mutations were identified: Gly14----Ser, Ser180----Asn, Arg157----His, Arg304----Trp, Gly324----Ser, Arg363----Trp, and Gly390----Arg. Six of these missense mutations involved conversion of a CpG dinucleotide in the sense strand to TpG or CpA, and six of the seven mutations alter a restriction enzyme site in the cDNA. Two mutations were observed in which the sequences encoded by a single exon (exon 7 or 13) were absent from the cDNA. One mutation is a G----C substitution in the last position of intron 15 resulting in splicing to a cryptic splice site within exon 16. There is extreme heterogeneity of mutations causing citrulinemia. This heterogeneity may prove typical for less common autosomal recessive human genetic diseases.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358466

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Simultaneous detection of mutant gene and transgene in ornithine carbamoyl-transferase-deficient spf-ash mice with rat OCT gene.

Authors:  K Kobayashi; M Horiuchi; A Yokokouji; T Shimada; T Saheki
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Argininosuccinate synthase: at the center of arginine metabolism.

Authors:  Ricci J Haines; Laura C Pendleton; Duane C Eichler
Journal:  Int J Biochem Mol Biol       Date:  2011

3.  Heterozygous mutations at the mut locus in fibroblasts with mut0 methylmalonic acidemia identified by polymerase-chain-reaction cDNA cloning.

Authors:  R Jansen; F D Ledley
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

4.  Favorable long-term outcome following severe neonatal hyperammonemic coma in a patient with argininosuccinate synthetase deficiency.

Authors:  Isabelle De Bie; Emmanuelle Lemyre; Marie Lambert
Journal:  JIMD Rep       Date:  2011-06-22

5.  Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia.

Authors:  T Yasuda; N Yamaguchi; K Kobayashi; I Nishi; H Horinouchi; M A Jalil; M X Li; M Ushikai; M Iijima; I Kondo; T Saheki
Journal:  Hum Genet       Date:  2000-12       Impact factor: 4.132

6.  Type II (adult onset) citrullinaemia: clinical pictures and the therapeutic effect of liver transplantation.

Authors:  S Ikeda; M Yazaki; Y Takei; T Ikegami; Y Hashikura; S Kawasaki; M Iwai; K Kobayashi; T Saheki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

7.  A search for the primary abnormality in adult-onset type II citrullinemia.

Authors:  K Kobayashi; N Shaheen; R Kumashiro; K Tanikawa; W E O'Brien; A L Beaudet; T Saheki
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

8.  Identification of a splice-site mutation in the aldolase B gene from an individual with hereditary fructose intolerance.

Authors:  C C Brooks; N Buist; J Tuerck; D R Tolan
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

9.  Argininosuccinate synthetase 1 depletion produces a metabolic state conducive to herpes simplex virus 1 infection.

Authors:  Sarah L Grady; John G Purdy; Joshua D Rabinowitz; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

10.  Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia.

Authors:  K Kobayashi; H Kakinoki; T Fukushige; N Shaheen; H Terazono; T Saheki
Journal:  Hum Genet       Date:  1995-10       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.